News for 'drug control'

All life-saving drugs may come under price cap

All life-saving drugs may come under price cap

Rediff.com25 Oct 2014

NPPA suggests expanding the list of essential medicines whose prices are controlled

Expert panel recommends granting emergency nod to Oxford vaccine

Expert panel recommends granting emergency nod to Oxford vaccine

Rediff.com2 Jan 2021

As for Bharat Biotech, the Subject Expert Committee (SEC) on COVID-19 of the CDSCO asked the firm to expedite volunteer recruitment for the ongoing clinical trial and said it may conduct interim efficacy analysis for further consideration of restricted emergency use approval for its vaccine Covaxin, they stated.

COVID-19 vaccine Covaxin enters phase-3 trials

COVID-19 vaccine Covaxin enters phase-3 trials

Rediff.com16 Nov 2020

Covaxin is being developed by Bharat Biotech, in collaboration with the Indian Council of Medical Research - National Institute of Virology.

Security forces gun down Pak intruder, nab 2 with 17 kg drugs in Poonch

Security forces gun down Pak intruder, nab 2 with 17 kg drugs in Poonch

Rediff.com9 Apr 2023

Officials said the infiltration attempt by three suspected terrorists was foiled in Shahpur sector around 2.15 am when troops guarding the LoC picked up their movement and engaged them in a gunfight.

'Depending on the product, the pricing pressure will always be there'

'Depending on the product, the pricing pressure will always be there'

Rediff.com3 Jun 2024

'That is a significant milestone for us and something we aspired for.'

Aarya Season 3 Review: Nothing New!

Aarya Season 3 Review: Nothing New!

Rediff.com3 Nov 2023

Aarya 3 feels like a recycled version of the previous seasons, discovers Mayur Sanap.

Hetero's generic version of remdesivir to be sold @ Rs 5,400/vial

Hetero's generic version of remdesivir to be sold @ Rs 5,400/vial

Rediff.com24 Jun 2020

The company is set to deliver the first set of 20,000 vials in two equal lots of 10,000 each, one of which will be immediately supplied to Hyderabad, Delhi, Gujarat, Tamil Nadu, Mumbai and other parts of Maharashtra, Hetero Healthcare said in a statement.

Drug cos may gain from polluting status review

Drug cos may gain from polluting status review

Rediff.com2 Dec 2008

A segment of drug companies such as tablet and capsule makers may benefit from the government's move to review polluting status of these companies, which may help them save costs on pollution control equipment.

Parl panel advises caution in emergency approval of vaccine

Parl panel advises caution in emergency approval of vaccine

Rediff.com21 Dec 2020

In a report submitted Monday to Rajya Sabha chairman and Vice President M Venkaiah Naidu, the Parliamentary Standing Committee on Home Affairs also said there was a need for a comprehensive public health law to keep a tab on private hospitals and check black-marketing of medicines.

Covid vaccination for children likely to start soon: Mandaviya

Covid vaccination for children likely to start soon: Mandaviya

Rediff.com28 Jul 2021

Union Health Minister Mansukh Mandaviya on Tuesday told Bharatiya Janata Party MPs that Covid vaccination for children is likely to start soon, sources said.

Govt reduces MNCs' drug margins

Govt reduces MNCs' drug margins

Rediff.com21 Aug 2007

The profit margins of multinational companies importing medicines into India have been hit with the National Pharmaceutical Pricing Authority starting strict scrutiny of price approval applications for imported products.

Phase 3 clinical trial of Oxford vaccine begins in Pune

Phase 3 clinical trial of Oxford vaccine begins in Pune

Rediff.com21 Sep 2020

"We have started the phase-III trials of the vaccine (candidate Covishield). We will administer dose to 150 to 200 volunteers," said Dr Muralidhar Tambe, Dean, Sassoon General Hospital.

DGCI denies emergency use nod to Sputnik-Light vaccine

DGCI denies emergency use nod to Sputnik-Light vaccine

Rediff.com1 Jul 2021

According to the recommendations of the Subject Expert Committee (SEC) meeting held on July 30, which have been approved by the Drugs Controller General of India (DCGI), Sputnik-Light is the same as the component-1 of Sputnik V and as its safety and immunogenicity data in the Indian population has already been generated in a trial here, there seems to be inadequate data and justification for conducting a separate, similar trial.

HC grants Pfizer temporary relief on cough syrup ban

HC grants Pfizer temporary relief on cough syrup ban

Rediff.com15 Mar 2016

The next hearing on Pfizer's plea is slated for March 21

Gennova's mRNA Covid vaccine gets nod for Phase 2-3 trials

Gennova's mRNA Covid vaccine gets nod for Phase 2-3 trials

Rediff.com25 Aug 2021

If things go according to plan, the vaccine would be available in the market by the end of this year.

Kerala prepares action plan for vaccination of teens

Kerala prepares action plan for vaccination of teens

Rediff.com2 Jan 2022

As the COVID-19 vaccination of children falling into the age bracket of 15 to 18 years is scheduled to begin from January 3, the Kerala health department has prepared an action plan for inoculation of all eligible beneficiaries.

Only Covaxin available for 15-18-yr-olds, for now

Only Covaxin available for 15-18-yr-olds, for now

Rediff.com27 Dec 2021

Healthcare and frontline workers and citizens above 60 years of age with comorbidities would be administered the third dose of the same vaccine they had been given before.

Serum Institute seeks regular marketing approval for Covishield

Serum Institute seeks regular marketing approval for Covishield

Rediff.com25 Oct 2021

If the DCGI grants regular marketing authorisation, Covishied will be the second vaccine in the world to receive such approval.

ICMR doing 3 studies on post-Covid heart attack among young

ICMR doing 3 studies on post-Covid heart attack among young

Rediff.com21 Jul 2023

The Indian Council of Medical Research is conducting three different studies to ascertain the facts regarding rising cases of cardiac arrest after the pandemic, Mandaviya said in response to a question in the Lok Sabha.

R&D firms should compensate trial injuries: DCGI

R&D firms should compensate trial injuries: DCGI

Rediff.com7 Dec 2010

The Drugs Controller General of India, the apex drug regulator, has included a new clause in the trial approval letters, making these firms also accountable for any possible adverse event.

Prices of 181 drugs revised

Prices of 181 drugs revised

Rediff.com24 Jun 2005

MP: Minor boy receives COVID-19 shot, falls sick

MP: Minor boy receives COVID-19 shot, falls sick

Rediff.com29 Aug 2021

A senior health official said the probe will find out how the teenager was given the shot even though the government is yet to roll out any anti-COVID 19 vaccination programme for minors.

Calm LoC spurs drug trafficking

Calm LoC spurs drug trafficking

Rediff.com27 Jun 2006

Figures available with the Narcotics Control Bureau reveal that 30 per cent of the drugs seized in the country during the last three years were produced in the remote areas of Afghanistan and reached India through the Indo-Pak border.

Bharat Biotech asked to submit phase 2 data of its Covid vaccine

Bharat Biotech asked to submit phase 2 data of its Covid vaccine

Rediff.com10 Oct 2020

The vaccine candidate -- 'Covaxin' -- is being indigenously developed by the Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).

After US, India to probe Ranbaxy's documents

After US, India to probe Ranbaxy's documents

Rediff.com22 May 2013

In what could be the beginning of fresh troubles for Ranbaxy Laboratories, which has just managed to settle long-pending issues with the US Department of Justice after agreeing to pay a penalty of $500 million, the health ministry in India, too, has decided to initiate a probe.

New drug policy welcome move: Pharma companies

New drug policy welcome move: Pharma companies

Rediff.com20 May 2013

Last week, the Department of Pharmaceuticals had notified the Drugs (Prices Control) Order 2013 under which prices of 348 medicines in the National List of Essential Medicines (NLEM) have been brought.

New drug price regime soon

New drug price regime soon

Rediff.com12 Aug 2005

Hyderabad: From software hub to drug haven of India

Hyderabad: From software hub to drug haven of India

Rediff.com14 Jul 2014

The focus on maintaining peace amid the violent protests demanding for a different state of Telangana has allowed drug peddlers and suppliers to set up shop in the Old City and carry out their nefarious activities, reports Rediff.com's Vicky Nanjappa.

India, Canada to tap pharma opportunities

India, Canada to tap pharma opportunities

Rediff.com23 Nov 2007

The drug regulatory agencies of India and Canada are planning to collaborate on improving the quality of drugs traded between the two countries, besides helping the industry in both the countries to tap the opportunities in the field of generic medicines and drug development.

Dr Reddy's soft-launches Sputnik V in India at Rs 995 per dose

Dr Reddy's soft-launches Sputnik V in India at Rs 995 per dose

Rediff.com15 May 2021

Dr Reddy's Laboratories on Friday soft-launched imported COVID-19 vaccine Sputnik V, with Deepak Sapra, a senior executive of the drug-maker, taking the first shot in Hyderabad.

Oxford vaccine may be first to get nod for emergency use in India

Oxford vaccine may be first to get nod for emergency use in India

Rediff.com26 Dec 2020

Once the UK drug regulator gives its approval to the Oxford vaccine, the expert committee on COVID-19 at the Central Drugs Standard Control Organisation (CDSCO) will hold its meeting and thoroughly review the safety and immunogenicity data from the clinical evaluations conducted abroad and in India before granting any emergency authorisation for the vaccine here, official sources said.

Covaxin gets nod for use in children above 12 years with riders

Covaxin gets nod for use in children above 12 years with riders

Rediff.com25 Dec 2021

The Subject Expert Committee on COVID-19 of the CDSCO on October 12 after deliberating Bharat Biotech's EUA application had recommended granting emergency use approval to Covaxin for use in the 12-18 years age group with certain conditions.

Abhishek flags off drive against drugs

Abhishek flags off drive against drugs

Rediff.com28 Mar 2011

Here's what your favourite celebrities have been up to.

Sameer Wankhede's foreign visits, expensive watches under CBI scanner

Sameer Wankhede's foreign visits, expensive watches under CBI scanner

Rediff.com15 May 2023

The details of FIR made public on Monday show that independent witness K P Gosavi and one Prabhakar Sail, now deceased, were included by the NCB in the Cordelia cruise ship drug raid on October 2, 2021 on the directions of Wankhede.

HC extends protection to Sameer Wankhede till June 23

HC extends protection to Sameer Wankhede till June 23

Rediff.com8 Jun 2023

The case of the CBI is that Wankhede and others accused had allegedly demanded Rs 25 crore bribe from actor Shah Rukh Khan for not framing his son Aryan Khan following alleged seizure of drugs from a cruise ship.

Hyderabad firm develops next-gen XBB1.5 Covid vax, awaits trial nod

Hyderabad firm develops next-gen XBB1.5 Covid vax, awaits trial nod

Rediff.com28 Dec 2023

As of now, Gennova Biopharmaceuticals has launched a vaccine, Gemcovac-OM, which is based on the Omicron variant.

Govt may cap margin on generic drugs

Govt may cap margin on generic drugs

Rediff.com23 Apr 2008

The non-branded generic drugs (sold under chemical names such as cetrizene, omeprazole and nimusulide), which constitute about 8 per cent of the Rs 30,000 crore (Rs 300 billion) Indian pharmaceutical market, is currently not subjected to any such margin cap and according to a study done by the department some of them such are even sold at a margin as high as 1,000 per cent in the market.

Wockhardt receives US nod for cardiac drug

Wockhardt receives US nod for cardiac drug

Rediff.com23 Jul 2010

Pharmaceutical and biotechnology major, Wockhardt has received final approval from the United States Food & Drug Administration for marketing the cardiac drug.

'Shortage of Tamiflu, masks won't be tolerated'

'Shortage of Tamiflu, masks won't be tolerated'

Rediff.com12 Aug 2009

The Union Health Ministry on Wednesday told the state governments to crack down on people hoarding and black-marketing swine flu drug Oseltamivir and masks used as protection against the disease, warning that their "shortage will not be tolerated."